AP-1: Linking hydrogen peroxide and oxidative stress to the control of cell proliferation and death

IUBMB Life

Volumn 52, Issue 1-2, 2001, Pages 17-24

  Karin, M ^a   Shaulian, E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; TRANSCRIPTION FACTOR AP 1;

CELL DEATH; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CONFERENCE PAPER; ENZYME ACTIVATION; ENZYME ACTIVITY; MALIGNANT TRANSFORMATION; OXIDATIVE STRESS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; HYDROGEN PEROXIDE; ONCOGENES; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

EID: 0036139794     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216540252774711     Document Type: Conference Paper

References (98)

1. Gene regulation by reactive oxygen species
2. The free radical theory of aging matures
3. Oxygen radicals and signaling
4. 2 for platelet-derived growth factor signal transduction
5. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
6. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity
7. c-JUN, and JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: Effect of FOS proteins
8. jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun
9. Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun
10. c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities
11. The role of the leucine zipper in the fos-jun interaction
12. The regulation of AP-1 activity by mitogen-activated protein kinases
13. AP-1 function and regulation
14. Control of cell cycle progression by c-Jun is p53 dependent
15. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression
16. The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest
17. c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activity
18. Promoter-specific trans-activation and inhibition mediated by JunB
19. Mammalian MAP kinase signalling cascades
20. Serum-regulated transcription by serum response factor (SRF): A novel role for the DNA binding domain
21. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C
22. 2. Role in cell survival following oxidant injury
23. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation
24. Transcription factor ATF2 regulation by the JNK signal transduction pathway
25. Rapid and preferential activation of the c-jun gene during the mammalian UV response
26. Requirement for los gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters
27. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain
28. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain
29. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation
30. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis
31. Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin
32. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1
33. Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-alpha signal transduction
34. The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase
35. 2 and vanadate in vitro
36. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor
37. AP-1 in cell proliferation and survival
38. The jun and fos protein families are both required for cell cycle progression in fibroblasts
39. Fos family members induce cell cycle entry by activating cyclin D1
40. Cell proliferation and cell cycle progression are not impaired in fibroblasts and ES cells lacking c-Fos
41. Targeted disruption of the murine junD gene results in multiple defects in male reproductive function
42. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation
43. A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture
44. AP-1 in mouse development and tumorigenesis
45. Functions of c-Jun in liver and heart development
46. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms
47. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
48. JunB is essential for mammalian placentation
49. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: Role in the control of cyclin D1 expression
50. Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage
51. Stepwise transformation of rat embryo fibroblasts: c-Jun, JunB, or JunD can cooperate with Ras for focus formation, but a c-Jun-containing heterodimer is required for immortalization
52. Oncogenic fas provokes premature cell senescence associated with accumulation of p53 and p16INK4a
53. JunD protects cells from p53-dependent senescence and apoptosis
54. Tumor surveillance via the ARF-p53 pathway
55. Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription
56. Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras
57. Deregulated expression of human c-jun transforms primary rat embryo cells in cooperation with an activated c-Ha-ras gene and transforms rat-1a cells as a single gene
58. c-fos protein can induce cellular transformation: A novel mechanism of activation of a cellular oncogene
59. Role of DNA 5-methylcytosine transferase in cell transformation by fos
60. Transformation by ras modifies AP1 composition and activity
61. Cellular transformation and malignancy induced by fas require c-jun
62. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73
63. Oncogenic transformation by fas and fos is mediated by c-Jun N-terminal phosphorylation
64. Autocrine growth and anchorage independence: Two complementing Jun-controlled genetic programs of cellular transformation
65. c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin
66. Deregulated c-fos expression interferes with normal bone development in transgenic mice
67. c-fos expression induces bone tumors in transgenic mice
68. c-fos is required for malignant progression of skin tumors
69. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion
70. Continuous c-fos expression precedes programmed cell death in vivo
71. Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells
72. Cascade induction of c-fos, c-myc, and heat shock 70K transcripts during regression of the rat ventral prostate gland
73. Altered gene expression in neurons during programmed cell death: Identification of c-jun as necessary for neuronal apoptosis
74. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death
75. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death
76. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
77. Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines
78. Mitogen-activated protein kinase cascades as regulators of stress responses
79. Induction of apoptosis by the transcription factor c-Jun
80. Induction of apoptosis by c-Fos protein
81. Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release
82. The absence of c-fos prevents light-induced apoptotic cell death of photoreceptors in retinal degeneration in vivo
83. c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents
84. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene
85. Dynamic regulation of c-Jun N-terminal kinase activity in mouse brain by environmental stimuli
86. Peripheral axotomy induces longterm c-Jun amino-terminal kinase-1 activation and activator protein-1 binding activity by c-Jun and junD in adult rat dorsal root ganglia in vivo
87. Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury
88. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway
89. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
90. Cooperation between STAT-3 and c-Jun suppresses Fas transcription
91. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression
92. c-jun is essential for normal mouse development and hepatogenesis
93. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development
94. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death
95. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway
96. Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3
97. NF-kB activation results in rapid inactivation of JNK in TNFa-treated Ewing sarcoma cells: A mechanism for the antiapoptotic effect of NF-kB
98. Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors